ADDIS ABABA, Ethiopia & KIGALI, Rwanda — In one of the most consequential structural shifts in global public health infrastructure, the Africa Centres for Disease Control and Prevention (Africa CDC) has scaled its Africa Pathogen Genomics Initiative (Africa PGI 2.0) into a permanent, decentralized genomic intelligence network spanning 35 African Union (AU) Member States. Transitioning from emergency pandemic response into routine molecular epidemiology, the initiative has expanded next-generation sequencing (NGS) operational capacity, established regional genomic biobanks, and integrated environmental wastewater surveillance across major metropolitan corridors.
According to synthesized surveillance bulletins from Africa CDC and clinical epidemiology data published in The Lancet Microbe and Nature Medicine, continental sequencing output has surged from fewer than 5,000 pathogen genomes per year in 2019 to over 150,000 genomes annually across viral, bacterial, and parasitic targets. Crucially, average turnaround times (TAT)—from primary clinical sample collection to actionable phylogenetic lineage assignment—have dropped from over 60 days when samples were routinely exported to overseas laboratories down to under 7 days within national public health institutes (NPHIs).
Post-COVID Genomic Infrastructure Expansion
Prior to 2020, pathogen genomics in Africa was heavily centralized, donor-reliant, and fragmented. More than 85% of African nations lacked in-country high-throughput sequencing hardware. Outbreak investigations for filoviruses, flaviviruses, and enteric pathogens required shipping physical biospecimens to laboratories in North America or Europe—a logistical hurdle that introduced weeks of customs delays and excluded African researchers from real-time data governance.
Launched as a $100 million public-private-philanthropic partnership involving Africa CDC, the Bill & Melinda Gates Foundation, Illumina, Oxford Nanopore Technologies, and the US CDC, Africa PGI was designed to dismantle this extractive model. Following the sequencing of more than 170,000 SARS-CoV-2 genomes—over 96% generated by African institutions—Africa CDC launched the Africa PGI 2.0 Flagship Framework in 2024–2026 to institutionalize pathogen genomics across endemic priorities.
Technological Architecture & Sequencing Throughput Data
Africa PGI employs a tiered hub-and-spoke laboratory architecture coordinated through the Regional Integrated Surveillance and Laboratory Networks (RISLNET). National Public Health Institutes operate benchtop platforms (Illumina MiSeq, NextSeq, and Oxford Nanopore MinION/GridION) for rapid, point-of-need targeted amplicon sequencing, while designated Continental Centers of Excellence handle high-throughput metagenomic Next-Generation Sequencing (mNGS) and deep microbial assembly.
Metagenomic Sequencing and Wastewater Intelligence
A central innovation under Africa PGI 2.0 is the integration of environmental and metagenomic surveillance through the WASTEWISE Project, deployed in collaboration with the African Society for Laboratory Medicine (ASLM). Operating across municipal wastewater treatment facilities, open drainage catchments, and market abattoirs in 14 African megacities (including Lagos, Kinshasa, Nairobi, and Addis Ababa), environmental metagenomics captures community pathogen circulation up to two weeks before clinical cases appear in hospital admissions.
Perspectives from Leadership and Technical Directors
Public health executives emphasize that genomic infrastructure provides the empirical backbone for Africa's New Public Health Order.
"Genomics is no longer an academic luxury; it is the foundational requirement for modern public health sovereignty. By moving sequencing capacity directly to the frontlines across 46 African Union member states, Africa CDC has ensured that our health security rests on in-house diagnostics, local scientists, and immediate data translation." — Dr. Jean Kaseya, Director-General, Africa Centres for Disease Control and Prevention (Africa CDC)
"The reduction of turnaround time from two months to less than seven days fundamentally changes epidemic response. When an outbreak of viral hemorrhagic fever or antimicrobial-resistant cholera occurs, national teams now generate genomic proof on-site, enabling immediate, targeted public health interventions rather than waiting for international confirmation." — Dr. Yenew Kebede, Head, Division of Laboratory Systems and Networks, Africa CDC
"During the 2024–2026 Mpox Clade Ib response, genomic data generated in African laboratories provided the international community with definitive transmission kinetics and mutation rates within days. Africa PGI has demonstrated that African researchers lead global pathogen discovery when equipped with proper sequencing infrastructure and bioinformatics pipelines." — Prof. Tulio de Oliveira, Director, Centre for Epidemic Response and Innovation (CERI) & KRISP, Stellenbosch University
Outbreak Containment & Biosecurity Implications
The real-world translation of Africa PGI’s infrastructure has transformed containment across three major infectious threats:
- Mpox Clade Ib Lineage Tracking (Central & Eastern Africa): Rapid genomic characterization in the Democratic Republic of the Congo, Rwanda, Burundi, and Uganda established that Clade Ib was transmitting efficiently via sustained human-to-human contact. Real-time phylogenetic trees informed targeted vaccine deployment and contact-tracing strategies.
- Antimicrobial-Resistant (AMR) Cholera Surveillance: Whole-genome sequencing of Vibrio cholerae O1 isolates across Southern Africa identified specific genomic acquisitions of integrative conjugative elements (ICE) conferring resistance to fluoroquinolones, prompting national authorities to adjust clinical treatment protocols to azithromycin.
- Genomic Biobanks and Pathogen Material Governance: Under Africa CDC's continental governance protocols, sequenced isolates are deposited into federated African genomic biobanks. This ensures that pathogen samples remain protected under equitable access and benefit-sharing frameworks, safeguarding intellectual property for domestic diagnostic and vaccine manufacturing.
Sources Cited
FIRAT Editorial Board
Institutional Research Desk · Foresight Institute of Research and Translation
The collective editorial and research translation board of FIRAT, synthesising peer-reviewed evidence, policy briefs, and division milestones across our seven foundational research pillars.
